Clinilabs, Inc.
423 W. 55th Street
4th Floor
New York
New York
10019
United States
Tel: 212-994-5100
Website: http://www.clinilabs.com/
35 articles about Clinilabs, Inc.
-
SureClinical and Clinilabs Announce Global Lunch and Learn Series for Clinical Operations
10/17/2019
SureClinical, a global provider of innovative cloud solutions for the health sciences market and Clinilabs Drug Development Corporation, a CNS-focused contract research organization, are sponsoring a global Lunch & Learn series demonstrating how sponsors can streamline and accelerate the clinical trials process.
-
Clinilabs, Inc. Has Been Awarded An Ethnic Bridging Study In Healthy Japanese Females
5/12/2014
-
Clinilabs, Inc. Welcomes Dr. Mina Pastagia To The Position Of Medical Director And Principal Investigator
4/11/2014
-
Clinilabs, Inc. Introduces Human Abuse Liability Service Offering At ASCPT 2014
2/11/2014
-
Clinilabs, Inc. Sponsors the American Diabetes Association's 2013 Step Out: Walk to Stop Diabetes
9/5/2013
-
Clinilabs, Inc. Launches Research Volunteer Authentication Initiative
4/2/2013
-
Clinilabs, Inc. Opens Phase I Unit in Eatontown, New Jersey
5/24/2012
-
Clinilabs, Inc. will Conduct Phase 1 Trial Using QTinno(R)
11/9/2011
-
Clinilabs, Inc. Release: Dr. Gary Zammit to Present on GCP Compliance for Phase I Studies
10/31/2011
-
Clinilabs, Inc., One of the First Medical Centers to Participate In a Clinical Study That Evaluates an Implantable Device to Treat Obstructive Sleep Apnea
9/29/2011
-
Clinilabs, Inc. Selected to Conduct a Phase I Clinical Trial of an Investigational New Drug for Insomnia
8/24/2011
-
Clinilabs, Inc. Selected for a Study of an Investigational Medication for Sleep in Healthy Volunteers
7/11/2011
-
Clinilabs, Inc. and Ambulatory Monitoring. Inc., Form Strategic Alliance - Merging the Most Respected Name in Activity Monitoring Equipment with the World's Leading Core Laboratory
6/21/2011
-
Clinilabs, Inc. to Exhibit at the 47th Annual Drug Information Association Meeting June 19-23
6/15/2011
-
Clinilabs, Inc. Selected for a Phase 2 Study of Major Depressive Disorder
6/8/2011
-
Clinilabs, Inc. Selected for A Phase 1 Study of an Investigational Patch Medication
5/25/2011
-
Clinilabs, Inc. Release: Dr. Gary Zammit to Present On the Safety and Efficacy of Hypnotic Drugs
5/10/2011
-
Clinilabs, Inc. Selected for a Phase I Study in Patients with Obstructive Sleep Apnea
4/15/2011
-
Clinilabs, Inc. Selected for a Phase I Study in Patients with Chronic Obstructive Pulmonary Disease
4/6/2011
-
Clinilabs, Inc. Welcomes Dr. Richard Johnson to Advisory Board
3/23/2011